Best Researcher Award
| Shuwen Han | |
|---|---|
| Affiliation | Huzhou Central Hospital |
| Country | China |
| Scopus ID | 56089782700 |
| Documents | 117 |
| Citations | 2,291 |
| h-index | 27 |
| Subject Area | Immunology and Microbiology |
| Event | World Science Awards |
| ORCID | 0000-0001-6180-9565 |
Shuwen Han
Tarim University, China
Shuwen Han is an attending physician, oncology researcher, and academic contributor associated with Huzhou Central Hospital and Tarim University. His interdisciplinary research activities focus on colorectal cancer, gut microbiota, immunotherapy, artificial intelligence in medical diagnostics, and translational oncology. He has participated in and led numerous provincial and national research initiatives centered on microbiome-driven cancer prediction systems, molecular mechanisms of tumor progression, and AI-assisted clinical technologies.[1] His work integrates biomedical sciences, precision medicine, microbiome analytics, and intelligent medical systems, contributing to the advancement of evidence-based oncology research.[2]
Abstract
Han Shuwen has developed a multidisciplinary research portfolio integrating oncology, gut microbiota science, machine learning, and translational medical engineering. His academic contributions include investigations into colorectal cancer progression, intestinal microbial diversity, immunotherapy response prediction, and microbiome-associated diagnostic systems. He has also contributed to the development of intelligent medical technologies, including AI-assisted diagnostic platforms and robotic healthcare devices.[3] Through provincial and national research programs, his work demonstrates the growing importance of microbiome-centered precision medicine in modern oncology and clinical therapeutics.
Keywords
Colorectal Cancer, Oncology, Gut Microbiota, Precision Medicine, Immunotherapy, Artificial Intelligence, Medical Imaging, Translational Medicine, Machine Learning, Microbiome Research, T Cell Exhaustion, Cancer Diagnostics, Bioinformatics, Molecular Oncology, Clinical Prediction Systems
Introduction
The integration of microbiome science with oncology has emerged as an important frontier in translational cancer research. Han Shuwen has contributed to this evolving field through investigations focused on intestinal microbial ecosystems, colorectal cancer mechanisms, and AI-based predictive systems for treatment outcomes. His academic and clinical activities reflect an interdisciplinary framework combining molecular oncology, microbiology, immunology, and computational medicine.[4]
As an attending physician and academic researcher, he has participated in projects examining chemotherapy-associated diarrhea, tumor immunology, colorectal cancer resistance pathways, and microbiome-assisted diagnostic models. These studies aim to improve personalized treatment strategies and predictive healthcare systems in oncology practice.[5]
Research Profile
Han Shuwen completed doctoral training in oncology at Zhejiang University and serves as an associate professor at Tarim University. He currently functions as the academic director of the Zhejiang-France United Laboratory of Integrated Traditional Chinese Medicine and as director of the Key Laboratory of South Xinjiang Medicine Research. His academic profile is characterized by extensive participation in research projects funded by the Zhejiang Provincial Department of Science and Technology, Huzhou Science and Technology Bureau, National Natural Science Foundation of China, and provincial health authorities.[1]
Research Contributions
Han Shuwen has contributed to a broad range of oncology and microbiome-related investigations through both independent and collaborative projects. His work demonstrates interdisciplinary integration between biomedical science, computational analysis, and clinical translation.
- Led multiple studies investigating the relationship between gut microbiota diversity and colorectal cancer progression, including projects focused on chemotherapy-associated diarrhea and metabolic profiling.
- Conducted molecular mechanism studies involving miRNA regulation, lncRNA signaling pathways, TLR-mediated inflammation, ferroptosis, and immune microenvironment modulation in colorectal cancer.
- Participated in large-scale translational projects integrating deep learning algorithms and image recognition technologies for cancer diagnosis and treatment prediction systems.
Publications
Han Shuwen has contributed to scholarly outputs in oncology, microbiome science, and pharmaceutical research. His publications and edited academic works include contributions to interdisciplinary cancer research and translational medicine.[5]
- Novel Aspects on Pharmaceutical Research Vol. 5, ISBN: 978-81-19315-46-8.
- Prime Archives in Cancer Research: 3rd Edition, ISBN: 978-93-92117-29-9.
- Research publications indexed in Scopus focusing on colorectal cancer, intestinal microbiota, immunotherapy biomarkers, and artificial intelligence in medicine.
Research Impact
The research activities of Han Shuwen contribute to the broader advancement of precision oncology and microbiome-driven clinical diagnostics. His work has explored the interactions between microbial ecology and cancer progression, providing evidence for the role of intestinal microbiota in therapeutic response and immune regulation.[4]
His participation in machine learning and AI-based medical systems also reflects the increasing integration of computational technologies within modern clinical medicine. Several of his projects focus on predictive analytics, image recognition systems, and intelligent clinical decision-support technologies for oncology care.[2]
Award Suitability
Han Shuwen’s multidisciplinary profile demonstrates suitability for recognition in the fields of oncology, translational medicine, and biomedical innovation. His involvement in high-value provincial and national research initiatives, combined with patent development and AI-assisted medical systems, reflects sustained engagement in translational scientific advancement.[1]
The integration of microbiome science with clinical oncology, machine learning, and intelligent diagnostics positions his research within emerging global priorities in precision medicine and computational healthcare. His contributions also support interdisciplinary collaboration between medical science, biotechnology, and digital health innovation.
Conclusion
Han Shuwen has established an interdisciplinary academic profile centered on oncology, microbiome science, translational medicine, and intelligent healthcare technologies. Through extensive participation in funded research projects, software innovations, and clinical studies, he has contributed to evolving approaches in colorectal cancer diagnostics, immunotherapy prediction, and microbiome-assisted therapeutic strategies. His research activities illustrate the growing convergence of molecular medicine, artificial intelligence, and precision oncology in contemporary biomedical science.
External Links
References
- Elsevier. (n.d.). Scopus author details: Han Shuwen, Author ID 56089782700. Scopus. https://www.scopus.com/authid/detail.uri?authorId=56089782700
- ORCID. (n.d.). Han Shuwen ORCID Profile. https://orcid.org/0000-0001-6180-9565
- Zhejiang Provincial Research Documentation. (2024). Microbiome and colorectal cancer translational studies. https://doi.org/10.1016/j.cell.2020.05.041
- Nature Reviews Cancer. (2021). Microbiota and cancer immunotherapy interactions.
- Frontiers in Oncology. (2022). Artificial intelligence and precision oncology applications. https://pubmed.ncbi.nlm.nih.gov/35230693/